Rhinocort
Developed to target inflammation in nasal passages, indicated to alleviate symptoms of allergic rhinitis.
Strengths: 100mcg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Rhinocort Aqua
- Therapeutic class
Corticosteroid
- Pharmacological class
Glucocorticoid
- Contraindications
hypersensitivity to budesonide
- Minor side effects
nasal irritation; sneezing; epistaxis
- Moderate side effects
headache; sore throat
- Dosage forms
Nasal spray, solution
- Administration route
Nasal use
- Prescription status
P
- Manufacturer
AstraZeneca
- Onset Time
12–24 hours
- Duration
24 hours
- Storage instructions
Store upright at room temperature.
- Drug interactions
cytochrome p450 inhibitors
- Age restrictions
Consult doctor for paediatric use.
- Pregnancy and breastfeeding
Pregnancy: Generally safe for topical use. Breastfeeding: Consult a physician.
Precautions and warnings
may take days for full effect; do not exceed recommended use; monitor for nasal irritation
Serious side effects
nasal septal perforation — requires immediate medical attention; anaphylaxis — requires immediate medical attention
Patient summary
Developed to target inflammation in nasal passages, indicated to alleviate symptoms of allergic rhinitis.
Mechanism of action
Budesonide exhibits potent glucocorticoid activity. By binding to glucocorticoid receptors, it suppresses inflammation by inhibiting mast cells, eosinophils, and cytokines, which effectively reduces allergic nasal congestion.
Rhinocort
Developed to target inflammation in nasal passages, indicated to alleviate symptoms of allergic rhinitis.
Editorial Notes
- Active ingredient(s): Budesonide
- Listed indication(s): Allergic Rhinitis, Nasal Polyps
Available option
- 3 inhalers - 100 mcg626-100-mcg-4072